1196552-03-0Relevant articles and documents
COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
-
Page/Page column 38, (2012/03/27)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.
COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS
-
Page/Page column 68, (2012/03/27)
The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity. wherein: and the rest of the variables are as specified in the claims.
COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
-
Page/Page column 142, (2009/12/23)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Ros, KDR, FMS, c-FMS, FLT3, c-Kit, JAK2, JAK3, Aurora, PDGFR, Lck, TrkA, TrkB, TrkC, IGF-1R, ALK4, ALK5 and ALK or combinations thereof.